SUPERGENICS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5 MYR | -1.96% |
|
-.--% | +117.39% |
| Apr. 02 | Supergenics Seeks More Time to Complete Private Share Placement | MT |
| Feb. 29 | Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 10.99M 2.33M | Sales 2022 | 10.72M 2.28M | Capitalization | 27.44M 5.83M |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | 2.69 x |
| Net Debt 2021 | 3.51M 746K | Net Debt 2022 | 4.68M 995K | EV / Sales 2022 | 3 x |
| P/E ratio 2021 |
1,284
x | P/E ratio 2022 |
79.3
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 28.56% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.96% | ||
| 3 months | +117.39% | ||
| 6 months | +117.39% | ||
| Current year | +117.39% |
Current year
0.31
0.51
1 year
0.220.51
3 years
0.220.51
5 years
0.220.51
10 years
0.220.51
| Managers | Title | Age | Since |
|---|---|---|---|
Bii Chau Tan
CEO | Chief Executive Officer | 46 | 19-04-23 |
Yuet Chyn Wong
SEC | Corporate Secretary | - | 22-06-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fun Kim Ng
BRD | Director/Board Member | 59 | 19-04-23 |
Bii Chau Tan
CEO | Chief Executive Officer | 46 | 19-04-23 |
Kiat Yang Chan
BRD | Director/Board Member | 44 | 22-01-27 |
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated turnkey solutions, Biomedical and Investment holding. The Company is engaged in the provision of integrated turnkey solutions for the related development of cleanroom and the provision of related maintenance services. The Biomedical segment is engaged in the provision of administrative health care services and operating of medical laboratories and developing of medical treatment and wellness products. The Company provides facility planning, designing, constructing, installing, validating, monitoring and maintaining cleanrooms in order to create an indoor environment suitable for activities which require a certain air quality. Its subsidiaries include Supergenics Solution Sdn Bhd, Supergenics Life Science Sdn Bhd and Supergenics Therapeutic Sdn Bhd.
Sector
Construction & Engineering
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +117.39% | 12.33M | |
| +1.01% | 71.21B | |
| +1.73% | 57.12B | |
| +25.63% | 39.69B | |
| +22.45% | 33.86B | |
| +11.27% | 29.11B | |
| +21.48% | 22.01B | |
| +12.46% | 19.05B | |
| +80.34% | 18.26B | |
| +35.92% | 17.9B |
- Stock Market
- Equities
- SGBHD Stock
